Skip to main content
SpringerLink
Log in

Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?

  • Practice Point
  • Published:

From Nature Clinical Practice Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. (No authors listed) (2003) NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 19: 1–46

  2. Backmund M et al. (2003) Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol 18: 563–538

    Article  Google Scholar 

  3. Sylvestre DL (2005) Treating hepatitis C virus infection in active substance users. Clin Infect Dis 40 (Suppl 5): S321–S324

    Article  Google Scholar 

  4. Schaefer M et al. (2004) Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 99: 1167–1175

    Article  Google Scholar 

  5. Edlin BR (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36 (Suppl 1): S210–S219

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor in Medicine at the Duke University Medical Center, Durham, NC, USA

    Keyur Patel

Authors
  1. Keyur Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keyur Patel.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, K. Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?. Nat Rev Gastroenterol Hepatol 3, 368–369 (2006). https://doi.org/10.1038/ncpgasthep0547

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0547

  • Springer Nature Limited

Search

Navigation